Effect of dietary supplementation of Bacillus coagulans or yeast hydrolysates on growth performance, antioxidant activity, cytokines and intestinal microflora of growing-finishing pigs
- 2019-12
- Animal Nutrition 5(4)
- Runqi Fu
- Daiwen Chen
- G. Tian
- P. Zheng
- X. Mao
- Jie Yu
- Jun He
- Zhiqing Huang
- Yuheng Luo
- B. Yu
- PubMed: 31890913
- DOI: 10.1016/j.aninu.2019.06.003
Abstract
This study was to investigate the effects of dietary supplementation of Bacillus coagulans (BC) and yeast hydrolysates (YH) on growth performance, antioxidant activity, cytokines and intestinal microflora of growing-finishing pigs. Thirty-six barrows (initial BW = 26.87 ± 2.65 kg) were assigned randomly to 3 treatments with 4 replicates, 3 pigs per replicate. Pigs in the control group (CON) were fed a basal diet, and the diets for the other 2 groups were the basal diet plus BC at 200 mg/kg and the basal diet plus YH at 3,000 mg/kg. The trial lasted for 104 d. Compared with CON, YH treatment significantly increased average daily gain (ADG) and average daily feed intake (ADFI) during the finishing phase (P < 0.05), and significantly enhanced ADG during the overall period (P < 0.05). Dietary inclusion of BC tended to increase ADFI during the finishing period (P = 0.08). Compared with CON, BC treatment improved lysozyme (LZM), complement 3 (C3), complement 4 (C4), interlenkin-10 (IL-10) and total antioxidant capacity (T-AOC) level in serum (P < 0.05). Dietary inclusion of YH enhanced the serum IL-10 level (P < 0.05) and tended to increase T-AOC level (P = 0.06). Dietary inclusion of YH elevated (P < 0.05) the number of Lactobacillus and Bacillus in cecal contents of pigs, promoted the populations of Bifidobacterium and Bacillus in colonic contents. Moreover, the BC diet increased (P < 0.05) the count of Bifidobacterium in colonic contents. These results indicated that dietary BC supplementation is beneficial to improve the immunity. Dietary YH supplementation promoted the growth performance and the populations of beneficial bacteria in the hindgut of the growing-finishing pigs.
Keywords: Antioxidant activity; Bacillus coagulans; Growth performance; Immunity; Intestinal microflora; Yeast hydrolysates.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bacillus coagulans | Improved Immune Function | Beneficial | Moderate |
Bacillus coagulans | Increased Bifidobacterium Levels | Beneficial | Moderate |
Bacillus coagulans LactoSpore 1 billion CFU | Improved Immune Function | Beneficial | Moderate |
Bacillus coagulans LactoSpore 1 billion CFU | Improved Microflora Composition | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Improved Immune Function | Beneficial | Moderate |
Bacillus coagulans MTCC 5856 | Increased Bifidobacterium Levels | Beneficial | Moderate |
Bacillus coagulans ProDura | Improved Immune Function | Beneficial | Moderate |
Bacillus coagulans ProDura | Increased Beneficial Gut Bacteria | Beneficial | Moderate |
Bacillus coagulans SC208 | Improved Gut Microbiota | Beneficial | Moderate |
Bacillus coagulans SC208 | Improved Immune Function | Beneficial | Moderate |
Bacillus coagulans SNZ-1969 | Improved Immune Function | Beneficial | Moderate |
Bacillus coagulans SNZ-1969 | Increased Beneficial Gut Microbiota | Beneficial | Moderate |
Bacillus coagulans Unique IS-2 | Improved Immune Function | Beneficial | Moderate |
Bacillus coagulans Unique IS-2 | Increased Bifidobacterium Levels | Beneficial | Moderate |